Leukocyte profiles in blood and CSF distinguish neurosarcoidosis from multiple sclerosis
Apr 1, 2020·,,,,,,,·
0 min read
Michael Heming
Lisa Lohmann
Andreas Schulte-Mecklenbeck
Tobias Brix
Catharina C Gross
Heinz Wiendl
Luisa Klotz
Gerd Meyer Zu Hörste
Abstract
Distinguishing neurosarcoidosis (NS) from multiple sclerosis (MS) remains challenging and available parameters lack discriminatory power. Comprehensive flow cytometry data of blood and CSF leukocytes of patients with NS (n = 24), MS (n = 49) and idiopathic intracranial hypertension (IIH, n = 52) were analyzed by machine learning algorithms. NS featured a specific immune cell pattern with increased activated CD4+ T cells in CSF and increased plasma cells in blood. Combining blood and CSF parameters improved the differentiation. We thereby identify and independently validate a multi-dimensional model of blood and CSF supporting the difficult differential diagnosis between NS and MS.
Type
Publication
Journal of Neuroimmunology